Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CoStar Group
CSGP
$11.7B
| $41.2M | 0.04% |
591,365
+4,663
| +0.8% | +$324K |
|
202
First Bancorp
FBNC
$2.6B
| $41.1M | 0.04% |
1,122,307
+120,100
| +12% | +$4.42M |
|
203
CONMED
CNMD
$1.39B
| $40.5M | 0.04% |
505,806
+4,953
| +1% | +$467K |
|
204
Enbridge
ENB
$119B
| $40.4M | 0.04% |
1,090,683
-470,171
| -30% | -$19.8M |
|
|
EVOP
205
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $39.9M | 0.04% |
1,198,161
-217,150
| -15% | -$6.71M |
|
206
Avient
AVNT
$3.33B
| $39.8M | 0.04% |
1,314,084
-274,997
| -17% | -$11.4M |
|
|
ENLC
207
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $39.8M | 0.04% |
4,477,283
+2,877,340
| +180% | +$27.6M |
|
208
Syndax Pharmaceuticals
SNDX
$1.69B
| $39.6M | 0.04% |
+1,649,795
| New | +$37M |
|
209
MakeMyTrip
MMYT
$5.36B
| $39.5M | 0.04% |
1,288,261
-33,344
| -3% | -$1.03M |
|
210
Adecoagro
AGRO
$1.44B
| $39.5M | 0.04% |
4,769,722
+1,426,974
| +43% | +$12M |
|
211
Kirby Corp
KEX
$7.01B
| $38.8M | 0.04% |
637,851
+119,633
| +23% | +$7.66M |
|
212
Cousins Properties
CUZ
$5.19B
| $38.7M | 0.04% |
1,658,461
+160,507
| +11% | +$4.54M |
|
213
Amgen
AMGN
$208B
| $38.5M | 0.04% |
170,872
+3,292
| +2% | +$798K |
|
214
Citigroup
C
$222B
| $38.5M | 0.04% |
924,203
-368,329
| -28% | -$18.2M |
|
215
Plains GP Holdings
PAGP
$5.21B
| $37.9M | 0.04% |
3,474,054
+358,027
| +11% | +$4.1M |
|
216
Apollo Global Management
APO
$72.4B
| $37.8M | 0.04% |
812,416
+91,591
| +13% | +$5.03M |
|
217
Teledyne Technologies
TDY
$30.4B
| $37.6M | 0.04% |
111,507
+7,299
| +7% | +$2.79M |
|
218
Freshpet
FRPT
$2.93B
| $37.6M | 0.04% |
750,255
+288,416
| +62% | +$13.6M |
|
219
Hilton Worldwide
HLT
$72.1B
| $37.2M | 0.04% |
308,250
+17,049
| +6% | +$2.16M |
|
|
GLDD
220
DELISTED
Great Lakes Dredge & Dock
GLDD
| $37.1M | 0.04% |
4,900,918
-206,910
| -4% | -$2.17M |
|
221
On Holding
ONON
$12.1B
| $37.1M | 0.04% |
2,311,300
+1,157,250
| +100% | +$23.1M |
|
|
BRDG
222
DELISTED
Bridge Investment Group
BRDG
| $36.9M | 0.04% |
2,544,286
+316,400
| +14% | +$5.11M |
|
223
Wabtec
WAB
$49.1B
| $36.7M | 0.04% |
450,935
+168,958
| +60% | +$14.9M |
|
224
Pliant Therapeutics
PLRX
$64.4M
| $36.4M | 0.04% |
+1,740,977
| New | +$33.3M |
|
225
OGE Energy
OGE
$9.78B
| $35.8M | 0.04% |
982,521
| – | – |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.